Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | |||
|
blog:bpaddock:mri_contrast_gadolinium_toxicity [2017/03/11 02:27] bpaddock |
blog:bpaddock:mri_contrast_gadolinium_toxicity [2017/03/11 02:53] (current) bpaddock |
||
|---|---|---|---|
| Line 6: | Line 6: | ||
| body scans and recommends regulatory actions, including | body scans and recommends regulatory actions, including | ||
| suspension for some marketing authorisations. | suspension for some marketing authorisations. | ||
| + | |||
| + | The linear gadolinium products gadobenic acid, gadopentetic acid, gadodiamide, and gadoversetamide. | ||
| http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/03/news_detail_002708.jsp&mid=WC0b01ac058004d5c1 | http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/03/news_detail_002708.jsp&mid=WC0b01ac058004d5c1 | ||
